Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.
Key PointsPfizer has faced the challenges of declining coronavirus portfolio revenue and patent expirations in recent years.
Pfizer's stock price has plummeted by 34% over the past five years, leading to a 6% dividend yield that has caught the attention of investors seeking high yields. While a high dividend yield may seem attractive, a falling stock price often indicates underlying business troubles. Pfizer has been grappling with declining demand for its coronavirus products and losing exclusivity on several blockbuster drugs.
The company implemented a cost realignment plan, which was a positive development, but such measures typically require time and may not guarantee success in achieving key goals.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
